Endoscopic Cryotherapy of Lung and Bronchial Tumors: A Systematic Review.
10.3904/kjim.2011.26.2.137
- Author:
Seon Heui LEE
1
;
Won Jung CHOI
;
Sook Whan SUNG
;
Young Kyoon KIM
;
Chi Hong KIM
;
Jae Il ZO
;
Kwang Joo PARK
Author Information
1. National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't ; Review
- Keywords:
Cryotherapy;
Bronchoscopy;
Lung neoplasms;
Carcinoma, bronchogenic;
Airway obstruction
- MeSH:
Bronchial Neoplasms/mortality/pathology/*surgery;
*Bronchoscopy/adverse effects;
Cryosurgery/adverse effects/*methods/mortality;
Humans;
Lung Neoplasms/mortality/pathology/*surgery;
Neoplasm Staging;
Risk Assessment;
Treatment Outcome
- From:The Korean Journal of Internal Medicine
2011;26(2):137-144
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: We made a systematic review and evaluation of endoscopic cryotherapy of endobronchial tumors, investigating safety and efficacy. METHODS: Qualified studies regarding endoscopic cryotherapy of lung tumors were systemically evaluated using available databases according to predefined criteria. RESULTS: In total, 16 publications were included in the final assessment. A narrative synthesis was performed because a formal meta-analysis was not viable due to the lack of controlled studies and study heterogeneity. Overall success rates for significant recanalization of the obstruction were approximately 80%, although they varied, depending on disease status in the patient population. Complications from the procedure developed in 0-11.1% of cases, most of which were minor and controlled by conservative management. Although limited data were available on comprehensive functional assessment, some studies showed that respiratory symptoms, pulmonary function tests, and performance status were significantly improved. CONCLUSIONS: Endoscopic cryotherapy was found to be a safe and useful procedure in the management of endobronchial tumors although its efficacy and appropriate indications have yet to be determined in well-designed controlled studies.
